// App-Quantinova.ai

7001.0 : A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of taxotere/cyclophosphamide-induced febrile neutropenia in patients with early-stage breast cancer.

Researchers

Presenter

  • Mark J. Clemons

Principal Investigators

  • Dean Fergusson

  • Anil A. Joy

  • Judith Meza-Junco

  • Julie A. Price Hiller

  • John Robert Mackey

  • Xiaofu Zhu

  • Mohammed FK Ibrahim

  • Bassam Mohammed Basulaiman

  • Arif Ali Awan

  • Marta Sienkiewicz

  • Lisa Vandermeer

  • Lacey D. Pitre

  • Nancy Alice Nixon

  • Brian Hutton

  • Gregory Russell Pond

  • John Frederick Hilton

Medical Centers

  • Research Associate, Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Clinical Epidemiology Program, The Ottawa Hospital Research Institute and University of Ottawa, Ottawa, ON, Canada

  • Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • Division of Clinical Sciences, Medical Oncology, Northern Ontario School of Medicine, Thunder Bay, ON, Canada

  • King Abdulaziz Medical City, Riyadh, Saudi Arabia

  • McGill University Health Centre, Montreal, QC, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Juravinski Cancer Center, Hamilton, Ontario, Canada.

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • School of Epidemiology and Public Health, Ottawa University, Ottawa, Ontario, Canada

  • McMaster University, Department of Surgery, Hamilton, ON, Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Adk3 + Docetaxel

  • Ciprofloxacin

  • Filgrastim

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

Phase

  • NA

Study Id's

  • NCT02173262

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved